Nasdaq · CIK 0001730430
KNSA Kiniksa Pharmaceuticals International, plc
Insider trading from SEC Form 4. Last filing 39 d ago. Close $79.78 on Oct 9, 2026, +116% from the 52-week low and -1% from the high.
Last 90 days
Net insider value
-$369k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$369k by 1 insider
Insiders on file
8
with a Form 4 at this company
Price and insider trades, last year
KNSAOct 9, 2026 · close 79.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Kiniksa Pharmaceuticals International, plc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $369k 4,600 shares | -14% | - | |
| 38Weak | Barry D Quart director sell | $836k 20,129 shares | -62% | +129% from low-3% from high | |
| 28Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $501k 12,048 shares | -42% | +129% from low-3% from high | |
| 47Moderate | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $1.8M 42,841 shares | -58% | +129% from low-3% from high | |
| 0Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $8,578 200 shares | -1% | +134% from low-0% from high | |
| 21Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $514k 12,470 shares | -35% | +128% from low0% from high | |
| 34Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $815k 19,900 shares | -39% | +123% from low-0% from high | |
| 40Moderate | John F. Paolini CHIEF MEDICAL OFFICER sell | $3.1M 82,542 shares | -57% | +104% from low-9% from high | |
| 2Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $4,100 100 shares | -0% | +117% from low-3% from high | |
| 40Moderate | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $2.0M 50,490 shares | -65% | +115% from low0% from high | |
| 50Moderate | Sanj K Patel CHAIRMAN & CEO sell | $10M 257,969 shares | -111% | +115% from low0% from high | |
| 27Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $466k 12,368 shares | -30% | +109% from low-2% from high | |
| 30Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $1.6M 42,000 shares | -55% | +113% from low0% from high | |
| 29Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $598k 16,400 shares | -32% | +101% from low-1% from high | |
| 30Weak | Ross Moat CHIEF CORP. & COMM. OFFICER sell | $124k 3,523 shares | -27% | +95% from low0% from high | |
| 45Moderate | Eben Tessari CHIEF OPERATING OFFICER sell | $3.5M 98,660 shares | -76% | +95% from low0% from high | |
| 16Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $383k 11,000 shares | -22% | +95% from low0% from high | |
| 29Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $536k 15,091 shares | -25% | +95% from low0% from high | |
| 29Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $547k 16,200 shares | -29% | +86% from low0% from high | |
| 60Notable | Thomas Malley director sell | $5.9M 177,769 shares | -287% | +80% from low-1% from high | |
| 29Weak | John F. Paolini CHIEF MEDICAL OFFICER sell | $955k 29,325 shares | -34% | +80% from low-1% from high | |
| 45Moderate | Eben Tessari CHIEF OPERATING OFFICER sell | $4.6M 138,614 shares | -74% | +82% from low0% from high | |
| 24Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $550k 17,000 shares | -34% | +81% from low0% from high | |
| 32Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $621k 18,889 shares | -41% | +81% from low0% from high | |
| 14Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $543k 18,900 shares | -28% | +59% from low-5% from high | |
| 23Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $489k 17,300 shares | -22% | +56% from low-6% from high | |
| 45Moderate | Eben Tessari CHIEF OPERATING OFFICER sell | $2.2M 70,867 shares | -86% | +67% from low0% from high | |
| 58Moderate | Barry D Quart director sell | $833k 27,448 shares | -141% | +67% from low0% from high | |
| 30Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $527k 18,299 shares | -40% | +60% from low0% from high | |
| 37Weak | Ross Moat CHIEF COMMERCIAL OFFICER sell | $801k 27,594 shares | -75% | +60% from low0% from high | |
| 22Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $437k 15,211 shares | -32% | +60% from low0% from high | |
| 50Moderate | Sanj K Patel CHAIRMAN & CEO sell | $2.3M 86,270 shares | -85% | +48% from low-3% from high | |
| 13Weak | Sanj K Patel CHAIRMAN & CEO sell | $63k 2,349 shares | -2% | +47% from low-4% from high | |
| 19Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $317k 12,000 shares | -14% | +47% from low-4% from high | |
| 14Weak | Sanj K Patel CHAIRMAN & CEO sell | $78k 2,872 shares | -3% | +41% from low-8% from high | |
| 22Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $471k 17,647 shares | -35% | +47% from low-4% from high | |
| 0Weak | John F. Paolini CHIEF MEDICAL OFFICER sell | $5,400 200 shares | -0% | +47% from low-4% from high | |
| 17Weak | Sanj K Patel CHAIRMAN & CEO sell | $219k 8,095 shares | -8% | +47% from low-4% from high | |
| 29Weak | Ross Moat CHIEF COMMERCIAL OFFICER sell | $283k 10,122 shares | -76% | +52% from low-0% from high | |
| 47Moderate | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $2.3M 88,395 shares | -128% | +42% from low-6% from high | |
| 40Moderate | Ross Moat CHIEF COMMERCIAL OFFICER sell | $2.3M 87,269 shares | -119% | +42% from low-6% from high | |
| 45Moderate | Ross Moat CHIEF COMMERCIAL OFFICER sell | $370k 18,259 shares | -66% | +10% from low-27% from high | |
| 11Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $246k 12,000 shares | -13% | +14% from low-25% from high | |
| 27Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $368k 15,944 shares | -41% | - | |
| 39Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $470k 20,343 shares | -58% | - | |
| 44Moderate | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $809k 36,372 shares | -61% | - | |
| 17Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $203k 9,051 shares | -25% | - | |
| 18Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $261k 12,409 shares | -14% | - | |
| 3Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $274k 14,000 shares | -15% | - | |
| 3Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $255k 14,000 shares | -14% | - | |
| 15Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $470k 23,017 shares | -19% | - | |
| 41Moderate | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $594k 27,829 shares | -87% | - | |
| 26Weak | Mark Ragosa CHIEF FINANCIAL OFFICER sell | $323k 15,116 shares | -47% | - | |
| 12Weak | Michael R Megna CHIEF ACCOUNTING OFFICER sell | $194k 8,646 shares | -25% | - | |
| 20Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $358k 17,000 shares | -14% | - | |
| 43Moderate | Sanj K Patel CHAIRMAN & CEO sell | $2.1M 89,561 shares | -53% | - | |
| 7Weak | Eben Tessari CHIEF OPERATING OFFICER sell | $457k 17,000 shares | -13% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share | +2,477 | - | - | 14,506 | 39 d ago |
| Jul 15, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | AGrant or award Class A Ordinary Share10b5-1 | +279 | $33.50 | $9,347 | 27,697 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share | +2,694 | - | - | 18,848 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +9,991 | - | - | 86,165 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share | +2,497 | - | - | 68,120 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +9,991 | - | - | 86,165 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share | +1,750 | - | - | 20,598 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +6,481 | - | - | 92,646 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share | +1,611 | - | - | 16,117 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share | +1,624 | - | - | 69,744 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +3,932 | - | - | 31,629 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +6,481 | - | - | 92,646 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share | +1,740 | - | - | 17,857 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share | +1,750 | - | - | 71,494 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +6,237 | - | - | 98,883 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +2,558 | - | - | 34,187 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share | +1,591 | - | - | 22,189 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +6,237 | - | - | 98,883 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share | +2,457 | - | - | 20,314 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +2,362 | - | - | 36,549 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share | +2,457 | - | - | 73,951 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +8,609 | - | - | 107,492 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share | +3,069 | - | - | 25,258 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +8,609 | - | - | 107,492 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | FTax withholding Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | -15,144 | $79.28 | $1.2M | 92,348 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | FTax withholding Class A Ordinary Share | -4,029 | $79.28 | $319k | 69,922 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +2,644 | - | - | 39,193 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | FTax withholding Class A Ordinary Share | -4,404 | $79.28 | $349k | 20,854 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | FTax withholding Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | -15,144 | $79.28 | $1.2M | 92,348 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | FTax withholding Class A Ordinary Share | -4,007 | $79.28 | $318k | 16,307 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | AGrant or award Restricted Share Unitderivative | +6,700 | $0.00 | $0 | 6,700 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | FTax withholding Class A Ordinary Share10b5-1 | -5,531 | $79.28 | $438k | 33,662 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | AGrant or award Restricted Share Unitderivative | +7,800 | $0.00 | $0 | 7,800 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | AGrant or award Restricted Share Unitderivative | +9,250 | $0.00 | $0 | 9,250 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | AGrant or award Share Optionderivative | +26,750 | $0.00 | $0 | 26,750 | 39 d ago |
| Sep 3, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -4,600 | $80.30 | $369k | 29,062 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | AGrant or award Share Optionderivative | +31,150 | $0.00 | $0 | 31,150 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | AGrant or award Share Optionderivative | +36,950 | $0.00 | $0 | 36,950 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | AGrant or award Restricted Share Unitderivative | +30,050 | $0.00 | $0 | 30,050 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Restricted Share Unitderivative | -2,457 | $0.00 | $0 | 7,371 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Restricted Share Unitderivative | -2,457 | $0.00 | $0 | 7,371 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Restricted Share Unitderivative | -3,069 | $0.00 | $0 | 9,206 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | AGrant or award Restricted Share Unitderivative10b5-1 | +3,650 | $0.00 | $0 | 3,650 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | AGrant or award Restricted Share Unitderivative | +30,050 | $0.00 | $0 | 30,050 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Restricted Share Unitderivative | -1,740 | $0.00 | $0 | 3,481 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | AGrant or award Share Optionderivative10b5-1 | +14,600 | $0.00 | $0 | 14,600 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | AGrant or award Share Optionderivative | +120,150 | $0.00 | $0 | 120,150 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 3,500 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Restricted Share Unitderivative | -1,591 | $0.00 | $0 | 3,182 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | AGrant or award Share Optionderivative | +120,150 | $0.00 | $0 | 120,150 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Restricted Share Unitderivative | -1,611 | $0.00 | $0 | 1,611 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Restricted Share Unitderivative10b5-1 | -2,644 | $0.00 | $0 | 7,931 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -8,609 | $0.00 | $0 | 25,826 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Restricted Share Unitderivative | -1,624 | $0.00 | $0 | 1,624 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 1,750 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -8,609 | $0.00 | $0 | 25,826 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -6,237 | $0.00 | $0 | 12,475 | 39 d ago |
| Sep 1, 2026 | Ross Moat CHIEF OPERATING OFFICER | MOption exercise Restricted Share Unitderivative | -2,477 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Restricted Share Unitderivative10b5-1 | -2,362 | $0.00 | $0 | 4,725 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -6,237 | $0.00 | $0 | 12,475 | 39 d ago |
| Sep 1, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Restricted Share Unitderivative | -2,497 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Restricted Share Unitderivative | -2,694 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -6,481 | $0.00 | $0 | 6,481 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Restricted Share Unitderivative10b5-1 | -2,558 | $0.00 | $0 | 2,557 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -6,481 | $0.00 | $0 | 6,481 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -9,991 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Sanj K Patel CHAIRMAN & CEO | MOption exercise Restricted Share Unitderivative | -9,991 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Michael R Megna CHIEF ACCOUNTING OFFICER | MOption exercise Restricted Share Unitderivative10b5-1 | -3,932 | $0.00 | $0 | 0 | 39 d ago |
| Dec 15, 2025 | Barry D Quart director | MOption exercise Class A Ordinary Share10b5-1 | +20,129 | $10.36 | $209k | 32,675 | Dec 17, 2025 |
| Dec 15, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +6,000 | $8.83 | $53k | 28,714 | Dec 17, 2025 |
| Dec 15, 2025 | Barry D Quart director | SOpen-market sale Class A Ordinary Share10b5-1 | -20,129 | $41.51 | $836k | 12,546 | Dec 17, 2025 |
| Dec 15, 2025 | Eben Tessari CHIEF OPERATING OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -12,048 | $41.56 | $501k | 16,666 | Dec 17, 2025 |
| Dec 15, 2025 | Barry D Quart director | MOption exercise Share Optionderivative10b5-1 | -20,129 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 15, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Share Optionderivative10b5-1 | -6,000 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +16,164 | $11.10 | $179k | 47,250 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +16,165 | $11.97 | $193k | 63,415 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +10,512 | $10.76 | $113k | 73,927 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -42,841 | $41.49 | $1.8M | 31,086 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -16,164 | $0.00 | $0 | 5,388 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -16,165 | $0.00 | $0 | 12,123 | Dec 10, 2025 |
| Dec 8, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -10,512 | $0.00 | $0 | 14,016 | Dec 10, 2025 |
| Nov 26, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +200 | $22.89 | $4,578 | 22,914 | Dec 1, 2025 |
| Nov 26, 2025 | Eben Tessari CHIEF OPERATING OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -200 | $42.89 | $8,578 | 22,714 | Dec 1, 2025 |
| Nov 26, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Share Optionderivative10b5-1 | -200 | $0.00 | $0 | 46,938 | Dec 1, 2025 |
| Nov 17, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 35,184 | Nov 19, 2025 |
| Nov 17, 2025 | Eben Tessari CHIEF OPERATING OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -645 | $40.08 | $26k | 34,539 | Nov 19, 2025 |
| Nov 17, 2025 | Eben Tessari CHIEF OPERATING OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -11,825 | $41.30 | $488k | 22,714 | Nov 19, 2025 |
| Nov 17, 2025 | Eben Tessari CHIEF OPERATING OFFICER | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 6,000 | Nov 19, 2025 |
| Nov 12, 2025 | Sanj K Patel CHAIRMAN & CEO | GGift Class A Ordinary Share | -111,794 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Nov 12, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +19,900 | $30.93 | $616k | 50,986 | Nov 14, 2025 |
| Nov 12, 2025 | Sanj K Patel CHAIRMAN & CEO | GGift Class A Ordinary Shareindirect: Held by The Anglia 2013 Revocable Trust | +111,794 | $0.00 | $0 | 111,794 | Nov 14, 2025 |
| Nov 12, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -19,900 | $40.94 | $815k | 31,086 | Nov 14, 2025 |
| Nov 13, 2025 | Sanj K Patel CHAIRMAN & CEO | GGift Class A Ordinary Shareindirect: Held by The Anglia 2013 Revocable Trust | -60,000 | $0.00 | $0 | 51,794 | Nov 14, 2025 |
| Nov 12, 2025 | Mark Ragosa CHIEF FINANCIAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -19,900 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Nov 13, 2025 | Sanj K Patel CHAIRMAN & CEO | GGift Class A Ordinary Shareindirect: Held by The Patel Family Irrevocable Trust of 2025 | +60,000 | $0.00 | $0 | 60,000 | Nov 14, 2025 |
| Oct 31, 2025 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +36,542 | $3.80 | $139k | 97,866 | Nov 4, 2025 |
| Oct 31, 2025 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Class A Ordinary Share10b5-1 | +46,000 | $8.83 | $406k | 143,866 | Nov 4, 2025 |
| Oct 31, 2025 | John F. Paolini CHIEF MEDICAL OFFICER | SOpen-market sale Class A Ordinary Share10b5-1 | -82,542 | $37.14 | $3.1M | 61,324 | Nov 4, 2025 |
| Oct 31, 2025 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -36,542 | $0.00 | $0 | 0 | Nov 4, 2025 |
| Oct 31, 2025 | John F. Paolini CHIEF MEDICAL OFFICER | MOption exercise Share Optionderivative10b5-1 | -46,000 | $0.00 | $0 | 0 | Nov 4, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Thomas Malleydirector
- Michael R MegnaCHIEF ACCOUNTING OFFICER
- Ross MoatCHIEF CORP. & COMM. OFFICER
- John F. PaoliniCHIEF MEDICAL OFFICER
- Sanj K PatelCHAIRMAN & CEO
- Barry D Quartdirector
- Mark RagosaCHIEF FINANCIAL OFFICER
- Eben TessariCHIEF OPERATING OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.